Sloan Kettering Executive Turns Over Windfall Stake in Biotech Start-Up by KATIE THOMAS and CHARLES ORNSTEIN

By KATIE THOMAS and CHARLES ORNSTEIN

With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards.

Published: September 28, 2018 at 08:00PM

from NYT Health https://ift.tt/2xOKzCv
via IFTTT

from WordPress https://ift.tt/2NPf1GS
via IFTTT